Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Tulmimetostat |
Trade Name | |
Synonyms | CPI0209|CPI-0209|CPI 0209 |
Drug Descriptions |
Tulmimetostat is a second-generation inhibitor of EZH1 and EZH2, which may lead to decreased tumor growth (J Clin Oncol 41, 2023 (suppl 16; abstr 3094)). |
DrugClasses | EZH1 inhibitor 5 EZH2 inhibitor 20 |
CAS Registry Number | 2567686-02-4 |
NCIT ID | C167347 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Tulmimetostat | Carboplatin Tulmimetostat | 0 | 1 |
Cisplatin + Tulmimetostat | Cisplatin Tulmimetostat | 0 | 0 |
Irinotecan + Tulmimetostat | Irinotecan Tulmimetostat | 0 | 1 |
Tulmimetostat | Tulmimetostat | 0 | 2 |